Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer. | Pathol Oncol Res | 2022 | 36110252 | PubTator, text mining | PubMed |
| Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma. | Front Genet | 2022 | 36110203 | PubTator, text mining | PubMed |
| Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. | J Nanobiotechnology | 2022 | 36109754 | PubTator, text mining | PubMed |
| The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion. | Curr Allergy Asthma Rep | 2022 | 36103081 | PubTator, text mining | PubMed |
| In vivo DNA-launched bispecific T cell engager targeting IL-13Rα2 controls tumor growth in an animal model of glioblastoma multiforme. | Mol Ther Oncolytics | 2022 | 36090479 | PubTator, text mining | PubMed |
| The interferon-γ receptor pathway: a new way to regulate CAR T cell-solid tumor cell adhesion. | Signal Transduct Target Ther | 2022 | 36085295 | PubTator, text mining | PubMed |
| Serum IL-13 Predicts Response to Golimumab in Bio-Naïve Ulcerative Colitis. | J Clin Med | 2022 | 36078882 | PubTator, text mining | PubMed |
| Paving the Way to Solid Tumors: Challenges and Strategies for Adoptively Transferred Transgenic T Cells in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36077730 | PubTator, text mining | PubMed |
| Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups. | Cancers (Basel) | 2022 | 36077612 | PubTator, text mining | PubMed |
| Critical Players and Therapeutic Targets in Chronic Itch. | Int J Mol Sci | 2022 | 36077340 | PubTator, text mining | PubMed |
| PDA-Based Drug Delivery Nanosystems: A Potential Approach for Glioma Treatment. | Int J Nanomedicine | 2022 | 36065287 | PubTator, text mining | PubMed |
| Diet-Induced Host-Microbe Interactions: Personalized Diet Strategies for Improving Inflammatory Bowel Disease. | Curr Dev Nutr | 2022 | 36060223 | PubTator, text mining | PubMed |
| Identification of key genes and pathways in chronic rhinosinusitis with nasal polyps and asthma comorbidity using bioinformatics approaches. | Front Immunol | 2022 | 36059464 | PubTator, text mining | PubMed |
| Secretory co-factors in next-generation cellular therapies for cancer. | Front Immunol | 2022 | 36059449 | PubTator, text mining | PubMed |
| Advanced Cell Therapies for Glioblastoma. | Front Immunol | 2022 | 36052072 | PubTator, text mining | PubMed |
National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs). | Wien Klin Wochenschr | 2022 | 36036323 | PubTator, text mining | PubMed |
| CD4+ T cell activation and inflammation in NASH-related fibrosis. | Front Immunol | 2022 | 36032141 | PubTator, text mining | PubMed |
| Human Cytomegalovirus and Human Herpesvirus 6 Coinfection of Dermal Fibroblasts Enhances the Pro-Inflammatory Pathway Predisposing to Fibrosis: The Possible Impact on Systemic Sclerosis. | Microorganisms | 2022 | 36014018 | PubTator, text mining | PubMed |
| Inflammatory Bowel Disease: A Review of Pre-Clinical Murine Models of Human Disease. | Int J Mol Sci | 2022 | 36012618 | PubTator, text mining | PubMed |
| Next Steps for Immunotherapy in Glioblastoma. | Cancers (Basel) | 2022 | 36011015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=34